Neuro-Innovators, Inc. published a study and its first patent in therapy.

Neuro-Innovators, Inc. Healing Brains with Neuroplastic Medicine™ About Us Neuro-Innovators (NIV) is a clinical-stage, first-in-class biopharmaceutical company pioneering neuroplastic medicine—therapies that unlock the brain’s innate ability to rewire, rebuild, and recover after injury or disease. Our Approach Traditional single-molecule drugs have consistently failed in neurology: too slow, too costly, too narrow in mechanism. We are changing the paradigm through a de-risked polypharmacology strategy: Engineered Combinations of FDA-approved drugs reformulated into a single oral capsule to act on multiple neuroplasticity pathways simultaneously. Accelerated Development using the FDA’s 505(b)(2) pathway, lowering risk, cost, and time to market. Lead Program NIV-001 is being developed to reduce chronic motor disability in the 7 million U.S. stroke survivors. Backed by FDA-accepted objective functional outcome metrics, NIV-001 offers lower regulatory risk, reduced trial costs, and faster timelines. Stroke recovery alone represents a $20B+ U.S. market opportunity. Future Pipeline Our platform extends beyond stroke recovery to other neurologic conditions, including: Dementia & cognitive decline Parkinson’s & movement disorders Traumatic Brain Injury (TBI) Our Mission We are redefining neuro-recovery medicine and building a new category of neuroplastic therapeutics to transform outcomes for millions of patients worldwide. 📩 Interested in partnering, investing, or collaborating? Connect with us or reach out at h.schroeder@neuro-innovators.com

Founded 2021